|
TET2 expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 3.220000E-01 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
9.662700E-03 |
| Normal-vs-Stage2 |
3.245000E-01 |
| Normal-vs-Stage3 |
2.546200E-01 |
| Normal-vs-Stage4 |
5.921500E-02 |
| Stage1-vs-Stage2 |
5.912000E-01 |
| Stage1-vs-Stage3 |
1.240890E-04 |
| Stage1-vs-Stage4 |
2.27019999999856E-05 |
| Stage2-vs-Stage3 |
9.710400E-02 |
| Stage2-vs-Stage4 |
3.238400E-02 |
| Stage3-vs-Stage4 |
3.675400E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
2.673600E-01 |
| Normal-vs-AfricanAmerican |
6.546800E-01 |
| Normal-vs-Asian |
3.085400E-01 |
| Caucasian-vs-AfricanAmerican |
2.516600E-01 |
| Caucasian-vs-Asian |
2.657400E-01 |
| AfricanAmerican-vs-Asian |
1.285380E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
4.600200E-01 |
| Normal-vs-Female |
2.572000E-01 |
| Male-vs-Female |
5.909200E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
6.272000E-01 |
| Normal-vs-Age(41-60Yrs) |
1.755640E-02 |
| Normal-vs-Age(61-80Yrs) |
6.391600E-01 |
| Normal-vs-Age(81-100Yrs) |
2.973400E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
5.337600E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
4.258200E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
2.599200E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
1.558410E-03 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
5.477900E-02 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
4.056400E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
1.341520E-02 |
| Normal-vs-Grade 2 |
4.324500E-03 |
| Normal-vs-Grade 3 |
8.305200E-01 |
| Normal-vs-Grade 4 |
5.396600E-04 |
| Grade 1-vs-Grade 2 |
4.414300E-02 |
| Grade 1-vs-Grade 3 |
1.432460E-04 |
| Grade 1-vs-Grade 4 |
1.015650E-03 |
| Grade 2-vs-Grade 3 |
6.832100E-04 |
| Grade 2-vs-Grade 4 |
1.77810000057121E-09 |
| Grade 3-vs-Grade 4 |
4.817600E-04 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
5.154900E-04 |
| Normal-vs-ccB subtype |
9.506000E-01 |
| ccA subtype-vs-ccB subtype |
3.436200E-04 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.943760E-01 |
| Normal-vs-N1 |
4.107600E-01 |
| N0-vs-N1 |
1.800400E-01 |
|
|
